Coherus Oncology, Inc. (CHRS)
1.41
-0.05
(-3.42%)
USD |
NASDAQ |
Aug 28, 16:00
1.40
-0.01
(-0.71%)
After-Hours: 20:00
Coherus Oncology Debt to Equity Ratio : 0.8905 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8905 |
| March 31, 2026 | 0.6916 |
| December 31, 2025 | 0.891 |
| September 30, 2025 | 0.6189 |
| June 30, 2025 | 0.4517 |
| March 31, 2025 | -1.632 |
| December 31, 2024 | -2.263 |
| September 30, 2024 | -3.404 |
| June 30, 2024 | -3.547 |
| March 31, 2024 | -5.879 |
| December 31, 2023 | -2.486 |
| September 30, 2023 | -3.583 |
| June 30, 2023 | -2.742 |
| March 31, 2023 | -2.442 |
| December 31, 2022 | -3.496 |
| September 30, 2022 | -4.949 |
| June 30, 2022 | -19.08 |
| March 31, 2022 | 34.25 |
| December 31, 2021 | 4.288 |
| September 30, 2021 | 3.203 |
| June 30, 2021 | 2.654 |
| March 31, 2021 | 3.271 |
| December 31, 2020 | 1.488 |
| September 30, 2020 | 1.630 |
| June 30, 2020 | 1.951 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.225 |
| December 31, 2019 | 1.814 |
| September 30, 2019 | 3.403 |
| June 30, 2019 | -46.51 |
| March 31, 2019 | -4.811 |
| December 31, 2018 | -2.671 |
| September 30, 2018 | 8.287 |
| June 30, 2018 | 1.620 |
| March 31, 2018 | -56.84 |
| December 31, 2017 | 3.193 |
| September 30, 2017 | 1.802 |
| June 30, 2017 | 3.140 |
| March 31, 2017 | 1.287 |
| December 31, 2016 | 4.884 |
| September 30, 2016 | 3.040 |
| June 30, 2016 | -1.636 |
| March 31, 2016 | -1.505 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.246 |
| June 30, 2014 | 0.1082 |
| March 31, 2014 | -0.655 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Enanta Pharmaceuticals, Inc. | 1.801 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 191.18M |
| Total Liabilities (Quarterly) | 130.34M |
| Shareholders Equity (Quarterly) | 60.84M |
| Current Ratio | 1.772 |
| Net Debt Paydown Yield | 22.69% |